Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.140
+0.160 (8.08%)
At close: Mar 9, 2026, 4:00 PM EDT
2.120
-0.020 (-0.93%)
After-hours: Mar 9, 2026, 7:33 PM EDT
Kiora Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 8 | 10 | 4 | 6 | 19 | 27 | |
| Market Cap Growth | -24.53% | 146.53% | -34.81% | -67.75% | -29.68% | -33.02% | |
| Enterprise Value | -11 | -19 | -1 | 1 | 8 | 25 | |
| Last Close Price | 2.14 | 3.30 | 4.70 | 30.87 | 543.60 | 1774.80 | |
| PE Ratio | - | 2.76 | - | - | - | - | |
| PS Ratio | - | 0.62 | - | - | - | 2252.98 | |
| PB Ratio | 0.33 | 0.38 | 0.66 | 0.54 | 1.31 | 2.79 | |
| P/TBV Ratio | 0.35 | 0.38 | 0.67 | 0.55 | 1.33 | 4.60 | |
| P/FCF Ratio | - | 1.16 | - | - | - | - | |
| P/OCF Ratio | - | 1.16 | - | - | - | - | |
| EV/Sales Ratio | - | - | - | - | - | 2038.07 | |
| Debt / Equity Ratio | 0.02 | 0.00 | 0.02 | 0.01 | 0.01 | 0.06 | |
| Debt / EBITDA Ratio | - | 0.01 | - | - | - | - | |
| Debt / FCF Ratio | - | 0.01 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.85 | -1.04 | -0.38 | -0.51 | -0.52 | -0.06 | |
| Net Debt / EBITDA Ratio | 2.04 | -4.77 | 0.27 | 0.55 | 0.73 | 0.08 | |
| Net Debt / FCF Ratio | 1.89 | -3.13 | 0.25 | 0.56 | 0.71 | 0.08 | |
| Asset Turnover | - | 0.64 | - | - | - | 0.00 | |
| Quick Ratio | 8.54 | 4.60 | 2.76 | 2.24 | 5.21 | 0.64 | |
| Current Ratio | 8.80 | 4.94 | 2.90 | 2.35 | 5.59 | 0.87 | |
| Return on Equity (ROE) | -32.58% | 22.56% | -142.88% | -104.54% | -113.30% | -83.93% | |
| Return on Assets (ROA) | -17.07% | 13.90% | -33.54% | -34.55% | -37.30% | -36.91% | |
| Return on Invested Capital (ROIC) | -350.21% | 254.39% | -186.67% | -171.87% | -131.74% | -124.59% | |
| Return on Capital Employed (ROCE) | -34.20% | 18.30% | -72.00% | -69.60% | -57.10% | -56.30% | |
| Earnings Yield | -108.83% | 36.30% | -311.53% | -220.45% | -72.08% | -25.26% | |
| FCF Yield | -127.66% | 86.37% | -237.92% | -169.24% | -56.21% | -27.01% | |
| Buyback Yield / Dilution | -27.45% | -666.73% | -561.21% | -203.73% | -110.04% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.